T1Disciplined
The documentary of Chris building a daily discipline system for life with Type 1. @T1Disciplined
Watch the seriesWellness and habit tracking only. Not medical advice. Not for treatment decisions. Talk to your care team.
Hey, I'm Chris. I've lived with Type 1 diabetes for years, and I'll be honest: I haven't always managed it well. I had the tech, a Dexcom and an Omnipod, but I still wasn't hitting my goals.
So I started building my own system. It's a daily report that pulls my glucose, insulin, workouts, meals and habits into one place, plus an AI bot that keeps me accountable every morning and night. I think I've found my secret sauce, and T1Disciplined is the documentary of whether it actually works.
This channel is about discipline: walking, meal prep, workouts, staying in the Word, and owning the small choices every day. It's also about community, because nobody should fight the T1D battle alone. Let's get locked in and win it together.
Not medical advice. Talk to your care team about any treatment decisions.
But they that wait upon the LORD shall renew their strength; they shall mount up with wings as eagles; they shall run, and not be weary; and they shall walk, and not faint.
Isaiah 40:31 (KJV)
Encouragement for the daily grind. Faith keeps me going; it is not a treatment or cure for diabetes. Keep working with your care team.
My real numbers from the daily report: last 30 days, wellness and habit trends only. Last updated: loading...
My personal tracking, shared for transparency. Not medical advice. Not for treatment decisions. Your numbers and needs are different; talk to your care team.
You can get this report for your journey as well.
Click here
News summaries only. Not medical advice. Updated Oct 24, 2026.
The FDA approved Kerendia (finerenone) for adults with chronic kidney disease linked to type 1 diabetes, based on the FINE-ONE trial published in NEJM. Breakthrough T1D called it the first new therapy for this group in three decades.
Source: BayerMore than 80 sessions covered immunotherapies, cell therapies, AI and access to care. The next congress is set for Washington, D.C., in October 2027.
Source: Breakthrough T1DResearchers reported that 10 of 12 people in Vertex's zimislecel trial no longer needed insulin, and that Sana Biotechnology's immune-evading islet cells were still making insulin more than a year after transplant, without immune-suppressing drugs.
Source: Breakthrough T1D (Canada)A new trial pairs donor islet transplants with Eledon's investigational drug tegoprubart, and for the first time includes people with chronic kidney disease. In the earlier study, all 12 participants so far are off external insulin.
Source: Breakthrough T1DA European phase 2b trial in 141 people found low-dose IL-2 boosted regulatory immune cells but did not preserve insulin production at 12 months. Researchers say it may still be worth testing earlier in the disease or in combination.
Source: The Lancet Diabetes & EndocrinologyA review of human tissue research finds many insulin-making cells are still present at diagnosis but working poorly, and that immune changes show up before blood sugar rises, which could help line up treatments with disease stage.
Source: Nature Reviews EndocrinologyThe 10-day Libre Duo reads glucose and ketones from one sensor and alerts if ketones rise. Abbott says US rollout starts in December.
Source: Abbott · JAMA · Drug Delivery Businesstwiist, already cleared for T1D (ages 6+), is now cleared for adults with insulin-treated type 2. It works with Libre 3 Plus and Eversense 365, not Dexcom.
Source: MedTech Dive (Oct 19)A new add-on lets the Mobi pump be worn on the body with no tubing and switched back to tubed wear. Tandem plans a phased rollout after clearance.
Source: DiabetechOmnipod 5 users get weekly glucose and insulin reports on their phones, and clinicians get a combined view of settings and trends.
Source: InsuletA trial will test an algorithm feature that adjusts insulin around meals without the user entering carbs. Results will feed a future FDA submission.
Source: Breakthrough T1DTalk with your care team about any treatment or device.
Episode 1 drops soon. Subscribe to get notified.
Get notifiedNeed help setting up your bot? Email t1disciplined@proton.me or DM us on YouTube or TikTok (@T1Disciplined). We'll get back to you soon. Support is for bot setup only, not medical advice.
Community Message Board: Coming soon
A place for T1D folks to share wins, habits and encouragement. Nobody should fight the T1D battle alone.
Get notifiedJoin the free monthly newsletter and get the bot setup emailed to you.
Get the bot setup free →